dualyx
Technologiepark-Zwijnaarde 94
9052 Gent
BE
dualyx
Foundation date
21/11/2019
Sector
#Biotechnology - TherapeuticsSubsector
- #Therapeutics - Proteins
- #Other - Industrial Biotechnology
- #Other - Veterinary
- #Pharma - Cell therapy
- #Pharma - Gene therapy
- #Professional Services - IT services
Therapeutic areas
- #Diseases of the blood and blood-forming organs - immune disorders
- #Musculoskeletal system and connective tissue
- #Respiratory system
- #Skin and subcutaneous tissue
dualyx NV focuses on the discovery and development of highly innovative biologicals for the treatment of autoimmune and rare diseases. We aim to create long-lasting treatments for patients with a high unmet medical need.
Upcoming events
All events-
0106 '23
KNOWLEDGE FOR GROWTH 2023
Event by: flanders.bio -
0506 '23
BIO International Convention 2023
Event by: Biotechnology Innovation Organisation -
0604 '23
Innovation for Health 2023
Event by: Hyphen Projects
Latest news
More news-
Imec-onderzoekers leggen basis voor in vivo detectie van traag groeiende hersentumoren, met dank aan hyperspectrale camera
Friday February 3rd 2023
Read more
-
Weber joins Vivactis Group to reinforce its Market Access capabilities
Thursday February 2nd 2023
Read more
-
Mithra CDMO announces collaboration with VaRi Bioscience for the development of a long-acting product in women’s health
Thursday February 2nd 2023
Read more
Jobs
More jobs-
-
02/02/23
Flemish Brabant
Research associate to support the Single Cell & Microfluidics Expertise unit
Permanent
VIB -